M&A, growth investments, partnerships, and leadership moves across independent and specialty diagnostic labs, revenue cycle management, and healthcare technology management providers.
Quest Diagnostics partnered with Attunio to advance a minimal residual disease test milestone in specialty diagnostics.
Quest Diagnostics partnered with Attunio Health to provide diagnostic infrastructure for the newly launched precision psychiatry platform.
Quest Diagnostics and Getlabs partnered with newly launched Attunio Health to build out its precision psychiatry diagnostic infrastructure.
Quest Diagnostics received New York state approval to offer its Haystack minimal residual disease test.
Ensemble Health Partners secured a strategic growth investment from Thoreau to fund expansion.
Ensemble Health Partners is reportedly close to a $12 billion private equity acquisition deal.
Vizient acquired Empierus to strengthen its healthcare IT spend management and cost optimization capabilities.
Labcorp expanded its DPYD testing service to identify patient risk of chemotherapy toxicity.